Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Supply, Demand and Key Producers, 2026-2032
The global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market size is expected to reach $ 1759 million by 2032, rising at a market growth of 13.2% CAGR during the forecast period (2026-2032).
Percutaneous Transluminal Coronary Angioplasty (PTCA) drug-eluting balloon (DEB) catheters?often referred to as coronary drug-coated balloon (DCB) catheters?are drug?device combination angioplasty systems used in PTCA. The balloon surface is coated with an antiproliferative drug (commonly paclitaxel, with growing ?limus? exploration) plus an excipient/carrier matrix. During inflation, the catheter provides immediate lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia, thereby reducing restenosis and repeat interventions. The strategic proposition is ?leave nothing behind,? avoiding additional permanent metal/polymer layers?particularly valuable in coronary in-stent restenosis (ISR), small vessels, and selected bifurcation strategies?while increasingly integrating lesion preparation and intravascular imaging into a repeatable coronary repair pathway.In 2025, global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters production reached approximately 755 k units and price is 940 USD/Unit.The average gross profit margin of this product is 73%.
Commercial certainty has strengthened materially for coronary DEB/DCB catheters. The U.S. FDA?s 2024 approval of Boston Scientific?s AGENT? coronary DCB for ISR marked a watershed moment, effectively opening a compliant U.S. pathway for coronary DCB therapy. In parallel, Europe?s long-standing practice and guideline endorsement have reinforced replicability?major editorial commentary highlights broad European adoption and high-level guideline support for ISR use. For industry leaders, this is not merely a device win; it signals category expansion driven by evidence and compliance?shifting competition from a single product to a system-level value delivery around lesion selection, standardized technique, and discipline-building.
Constraints are defined by indication boundaries and reproducible engineering. In previously untreated, non-complex coronary artery disease, drug-coated balloon angioplasty has not been positioned as a straightforward default replacement for contemporary stenting strategies in recent reported evidence, underscoring the need for tighter lesion stratification and procedural standardization as adoption expands. As a drug?device combination, coronary DCBs are highly sensitive to coating integrity, particulate control, dose uniformity, and deliverability?where variability can quickly translate into clinical experience gaps and access risk, raising the bar for quality systems, supply stability, and lifecycle risk management.
Demand is moving from ?device choice? to ?repair solutions.? Hospitals and operators increasingly prioritize avoiding additional metal layers in ISR and reducing the complexity of future reinterventions?driving more routine integration of DEB/DCB with lesion preparation and intravascular imaging (IVUS/OCT), and repositioning the catheter from a consumable to a pathway tool. Reimbursement signals are also turning constructive: CMS has granted an add-on payment pathway for AGENT DCB use in eligible inpatient settings, supporting more structured hospital adoption and resource planning. Meanwhile, innovation is diversifying??limus?-based and low-/no-excipient approaches continue to progress with regulatory milestones in certain markets, accelerating multi-route iteration beyond a single drug platform.
Upstream differentiation is ultimately a ?materials?coating?validation? platform capability rather than a simple bill of materials. Core inputs include balloon films and catheter polymers (multi-durometer shafts, liners, reinforcement braids/coils), drug APIs (paclitaxel or limus agents) with crystallinity/particle control, excipient and solvent systems, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Coronary use is especially sensitive to deliverability and safety, forcing the supply chain to industrialize coating stability, particulate control, dose uniformity, and batch-release consistency as durable engineering capabilities that underpin long-term brand and channel credibility.
This report studies the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters total production and demand, 2021-2032, (K Units)
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters total production value, 2021-2032, (USD Million)
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters domestic production, consumption, key domestic manufacturers and share
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Eurocor, Teleflex, Yinyi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market, By Region:
1. How big is the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market?
2. What is the demand of the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market?
3. What is the year over year growth of the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market?
4. What is the production and production value of the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market?
5. Who are the key producers in the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market?
6. What are the growth factors driving the market demand?
Percutaneous Transluminal Coronary Angioplasty (PTCA) drug-eluting balloon (DEB) catheters?often referred to as coronary drug-coated balloon (DCB) catheters?are drug?device combination angioplasty systems used in PTCA. The balloon surface is coated with an antiproliferative drug (commonly paclitaxel, with growing ?limus? exploration) plus an excipient/carrier matrix. During inflation, the catheter provides immediate lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia, thereby reducing restenosis and repeat interventions. The strategic proposition is ?leave nothing behind,? avoiding additional permanent metal/polymer layers?particularly valuable in coronary in-stent restenosis (ISR), small vessels, and selected bifurcation strategies?while increasingly integrating lesion preparation and intravascular imaging into a repeatable coronary repair pathway.In 2025, global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters production reached approximately 755 k units and price is 940 USD/Unit.The average gross profit margin of this product is 73%.
Commercial certainty has strengthened materially for coronary DEB/DCB catheters. The U.S. FDA?s 2024 approval of Boston Scientific?s AGENT? coronary DCB for ISR marked a watershed moment, effectively opening a compliant U.S. pathway for coronary DCB therapy. In parallel, Europe?s long-standing practice and guideline endorsement have reinforced replicability?major editorial commentary highlights broad European adoption and high-level guideline support for ISR use. For industry leaders, this is not merely a device win; it signals category expansion driven by evidence and compliance?shifting competition from a single product to a system-level value delivery around lesion selection, standardized technique, and discipline-building.
Constraints are defined by indication boundaries and reproducible engineering. In previously untreated, non-complex coronary artery disease, drug-coated balloon angioplasty has not been positioned as a straightforward default replacement for contemporary stenting strategies in recent reported evidence, underscoring the need for tighter lesion stratification and procedural standardization as adoption expands. As a drug?device combination, coronary DCBs are highly sensitive to coating integrity, particulate control, dose uniformity, and deliverability?where variability can quickly translate into clinical experience gaps and access risk, raising the bar for quality systems, supply stability, and lifecycle risk management.
Demand is moving from ?device choice? to ?repair solutions.? Hospitals and operators increasingly prioritize avoiding additional metal layers in ISR and reducing the complexity of future reinterventions?driving more routine integration of DEB/DCB with lesion preparation and intravascular imaging (IVUS/OCT), and repositioning the catheter from a consumable to a pathway tool. Reimbursement signals are also turning constructive: CMS has granted an add-on payment pathway for AGENT DCB use in eligible inpatient settings, supporting more structured hospital adoption and resource planning. Meanwhile, innovation is diversifying??limus?-based and low-/no-excipient approaches continue to progress with regulatory milestones in certain markets, accelerating multi-route iteration beyond a single drug platform.
Upstream differentiation is ultimately a ?materials?coating?validation? platform capability rather than a simple bill of materials. Core inputs include balloon films and catheter polymers (multi-durometer shafts, liners, reinforcement braids/coils), drug APIs (paclitaxel or limus agents) with crystallinity/particle control, excipient and solvent systems, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Coronary use is especially sensitive to deliverability and safety, forcing the supply chain to industrialize coating stability, particulate control, dose uniformity, and batch-release consistency as durable engineering capabilities that underpin long-term brand and channel credibility.
This report studies the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters total production and demand, 2021-2032, (K Units)
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters total production value, 2021-2032, (USD Million)
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters domestic production, consumption, key domestic manufacturers and share
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Eurocor, Teleflex, Yinyi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Paclitaxel-based
- limus
- Other
- In-Stent Restenosi
- De Novo
- Small Vessel
- Semi-/Compliant
- Non-compliant
- Other
- Hospitals
- Clinics
- Others
- B. Braun
- Eurocor
- Teleflex
- Yinyi
1. How big is the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market?
2. What is the demand of the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market?
3. What is the year over year growth of the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market?
4. What is the production and production value of the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market?
5. Who are the key producers in the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Introduction
1.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Supply & Forecast
1.2.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value (2021 & 2025 & 2032)
1.2.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032)
1.2.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Pricing Trends (2021-2032)
1.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Region (Based on Production Site)
1.3.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Region (2021-2032)
1.3.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Region (2021-2032)
1.3.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Region (2021-2032)
1.3.4 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032)
1.3.5 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032)
1.3.6 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Major Market Trends
2 DEMAND SUMMARY
2.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Demand (2021-2032)
2.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption by Region
2.2.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption by Region (2021-2026)
2.2.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Forecast by Region (2027-2032)
2.3 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
2.4 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
2.5 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
2.6 Japan Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
2.7 South Korea Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
2.8 ASEAN Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
2.9 India Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Manufacturer (2021-2026)
3.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Manufacturer (2021-2026)
3.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Manufacturer (2021-2026)
3.4 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters in 2025
3.5.3 Global Concentration Ratios (CR8) for Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters in 2025
3.6 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market: Overall Company Footprint Analysis
3.6.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market: Region Footprint
3.6.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market: Company Product Type Footprint
3.6.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Comparison
4.1.1 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Comparison
4.2.1 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Comparison
4.3.1 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value (2021-2026)
4.4.3 United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2026)
4.5 China Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers and Market Share
4.5.1 China Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value (2021-2026)
4.5.3 China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2026)
4.6 Rest of World Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Paclitaxel-based
5.2.2 limus
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Type (2021-2032)
5.3.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Type (2021-2032)
5.3.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY USE SCENARIO
6.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size Overview by Use Scenario: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Use Scenario
6.2.1 In-Stent Restenosi
6.2.2 De Novo
6.2.3 Small Vessel
6.3 Market Segment by Use Scenario
6.3.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Use Scenario (2021-2032)
6.3.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Use Scenario (2021-2032)
6.3.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Use Scenario (2021-2032)
7 MARKET ANALYSIS BY BALLOON PLATFORM MECHANICS
7.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size Overview by Balloon Platform Mechanics: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Balloon Platform Mechanics
7.2.1 Semi-/Compliant
7.2.2 Non-compliant
7.2.3 Other
7.3 Market Segment by Balloon Platform Mechanics
7.3.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Balloon Platform Mechanics (2021-2032)
7.3.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Balloon Platform Mechanics (2021-2032)
7.3.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Balloon Platform Mechanics (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Application (2021-2032)
8.3.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Application (2021-2032)
8.3.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 B. Braun
9.1.1 B. Braun Details
9.1.2 B. Braun Major Business
9.1.3 B. Braun Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
9.1.4 B. Braun Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 B. Braun Recent Developments/Updates
9.1.6 B. Braun Competitive Strengths & Weaknesses
9.2 Eurocor
9.2.1 Eurocor Details
9.2.2 Eurocor Major Business
9.2.3 Eurocor Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
9.2.4 Eurocor Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Eurocor Recent Developments/Updates
9.2.6 Eurocor Competitive Strengths & Weaknesses
9.3 Teleflex
9.3.1 Teleflex Details
9.3.2 Teleflex Major Business
9.3.3 Teleflex Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
9.3.4 Teleflex Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Teleflex Recent Developments/Updates
9.3.6 Teleflex Competitive Strengths & Weaknesses
9.4 Yinyi
9.4.1 Yinyi Details
9.4.2 Yinyi Major Business
9.4.3 Yinyi Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
9.4.4 Yinyi Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Yinyi Recent Developments/Updates
9.4.6 Yinyi Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Chain
10.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Upstream Analysis
10.2.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Core Raw Materials
10.2.2 Main Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Mode
10.6 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Procurement Model
10.7 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Sales Model and Sales Channels
10.7.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Model
10.7.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Introduction
1.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Supply & Forecast
1.2.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value (2021 & 2025 & 2032)
1.2.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032)
1.2.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Pricing Trends (2021-2032)
1.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Region (Based on Production Site)
1.3.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Region (2021-2032)
1.3.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Region (2021-2032)
1.3.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Region (2021-2032)
1.3.4 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032)
1.3.5 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032)
1.3.6 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Major Market Trends
2 DEMAND SUMMARY
2.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Demand (2021-2032)
2.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption by Region
2.2.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption by Region (2021-2026)
2.2.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Forecast by Region (2027-2032)
2.3 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
2.4 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
2.5 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
2.6 Japan Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
2.7 South Korea Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
2.8 ASEAN Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
2.9 India Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Manufacturer (2021-2026)
3.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Manufacturer (2021-2026)
3.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Manufacturer (2021-2026)
3.4 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters in 2025
3.5.3 Global Concentration Ratios (CR8) for Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters in 2025
3.6 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market: Overall Company Footprint Analysis
3.6.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market: Region Footprint
3.6.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market: Company Product Type Footprint
3.6.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Comparison
4.1.1 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Comparison
4.2.1 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Comparison
4.3.1 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value (2021-2026)
4.4.3 United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2026)
4.5 China Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers and Market Share
4.5.1 China Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value (2021-2026)
4.5.3 China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2026)
4.6 Rest of World Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Paclitaxel-based
5.2.2 limus
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Type (2021-2032)
5.3.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Type (2021-2032)
5.3.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY USE SCENARIO
6.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size Overview by Use Scenario: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Use Scenario
6.2.1 In-Stent Restenosi
6.2.2 De Novo
6.2.3 Small Vessel
6.3 Market Segment by Use Scenario
6.3.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Use Scenario (2021-2032)
6.3.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Use Scenario (2021-2032)
6.3.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Use Scenario (2021-2032)
7 MARKET ANALYSIS BY BALLOON PLATFORM MECHANICS
7.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size Overview by Balloon Platform Mechanics: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Balloon Platform Mechanics
7.2.1 Semi-/Compliant
7.2.2 Non-compliant
7.2.3 Other
7.3 Market Segment by Balloon Platform Mechanics
7.3.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Balloon Platform Mechanics (2021-2032)
7.3.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Balloon Platform Mechanics (2021-2032)
7.3.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Balloon Platform Mechanics (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Application (2021-2032)
8.3.2 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Application (2021-2032)
8.3.3 World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 B. Braun
9.1.1 B. Braun Details
9.1.2 B. Braun Major Business
9.1.3 B. Braun Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
9.1.4 B. Braun Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 B. Braun Recent Developments/Updates
9.1.6 B. Braun Competitive Strengths & Weaknesses
9.2 Eurocor
9.2.1 Eurocor Details
9.2.2 Eurocor Major Business
9.2.3 Eurocor Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
9.2.4 Eurocor Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Eurocor Recent Developments/Updates
9.2.6 Eurocor Competitive Strengths & Weaknesses
9.3 Teleflex
9.3.1 Teleflex Details
9.3.2 Teleflex Major Business
9.3.3 Teleflex Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
9.3.4 Teleflex Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Teleflex Recent Developments/Updates
9.3.6 Teleflex Competitive Strengths & Weaknesses
9.4 Yinyi
9.4.1 Yinyi Details
9.4.2 Yinyi Major Business
9.4.3 Yinyi Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
9.4.4 Yinyi Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Yinyi Recent Developments/Updates
9.4.6 Yinyi Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Chain
10.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Upstream Analysis
10.2.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Core Raw Materials
10.2.2 Main Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Mode
10.6 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Procurement Model
10.7 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Sales Model and Sales Channels
10.7.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Model
10.7.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Region (2021-2026) & (USD Million)
Table 3. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Region (2027-2032) & (USD Million)
Table 4. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Region (2021-2026)
Table 5. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Region (2027-2032)
Table 6. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Region (2021-2026) & (K Units)
Table 7. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Region (2027-2032) & (K Units)
Table 8. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Region (2021-2026)
Table 9. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Region (2027-2032)
Table 10. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Major Market Trends
Table 13. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption by Region (2021-2026) & (K Units)
Table 15. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Producers in 2025
Table 18. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Producers in 2025
Table 20. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Company Evaluation Quadrant
Table 22. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Site of Key Manufacturer
Table 24. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market: Company Product Type Footprint
Table 25. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market: Company Product Application Footprint
Table 26. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Competitive Factors
Table 27. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters New Entrant and Capacity Expansion Plans
Table 28. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Mergers & Acquisitions Activity
Table 29. United States VS China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share (2021-2026)
Table 37. China Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share (2021-2026)
Table 42. Rest of World Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share (2021-2026)
Table 47. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Type (2021-2026) & (K Units)
Table 49. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Type (2027-2032) & (K Units)
Table 50. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Type (2021-2026) & (USD Million)
Table 51. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Type (2027-2032) & (USD Million)
Table 52. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Table 55. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Use Scenario (2021-2026) & (K Units)
Table 56. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Use Scenario (2027-2032) & (K Units)
Table 57. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Use Scenario (2021-2026) & (USD Million)
Table 58. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Use Scenario (2027-2032) & (USD Million)
Table 59. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Use Scenario (2021-2026) & (US$/Unit)
Table 60. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Use Scenario (2027-2032) & (US$/Unit)
Table 61. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Table 62. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 63. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Balloon Platform Mechanics (2027-2032) & (K Units)
Table 64. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Balloon Platform Mechanics (2021-2026) & (USD Million)
Table 65. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Balloon Platform Mechanics (2027-2032) & (USD Million)
Table 66. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 67. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Balloon Platform Mechanics (2027-2032) & (US$/Unit)
Table 68. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Application (2021-2026) & (K Units)
Table 70. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Application (2027-2032) & (K Units)
Table 71. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Application (2021-2026) & (USD Million)
Table 72. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Application (2027-2032) & (USD Million)
Table 73. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Application (2027-2032) & (US$/Unit)
Table 75. B. Braun Basic Information, Manufacturing Base and Competitors
Table 76. B. Braun Major Business
Table 77. B. Braun Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
Table 78. B. Braun Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. B. Braun Recent Developments/Updates
Table 80. B. Braun Competitive Strengths & Weaknesses
Table 81. Eurocor Basic Information, Manufacturing Base and Competitors
Table 82. Eurocor Major Business
Table 83. Eurocor Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
Table 84. Eurocor Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Eurocor Recent Developments/Updates
Table 86. Eurocor Competitive Strengths & Weaknesses
Table 87. Teleflex Basic Information, Manufacturing Base and Competitors
Table 88. Teleflex Major Business
Table 89. Teleflex Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
Table 90. Teleflex Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Teleflex Recent Developments/Updates
Table 92. Teleflex Competitive Strengths & Weaknesses
Table 93. Yinyi Basic Information, Manufacturing Base and Competitors
Table 94. Yinyi Major Business
Table 95. Yinyi Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
Table 96. Yinyi Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Yinyi Recent Developments/Updates
Table 98. Yinyi Competitive Strengths & Weaknesses
Table 99. Global Key Players of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Upstream (Raw Materials)
Table 100. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Typical Customers
Table 101. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Typical Distributors
Table 1. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Region (2021-2026) & (USD Million)
Table 3. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Region (2027-2032) & (USD Million)
Table 4. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Region (2021-2026)
Table 5. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Region (2027-2032)
Table 6. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Region (2021-2026) & (K Units)
Table 7. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Region (2027-2032) & (K Units)
Table 8. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Region (2021-2026)
Table 9. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Region (2027-2032)
Table 10. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Major Market Trends
Table 13. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption by Region (2021-2026) & (K Units)
Table 15. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Producers in 2025
Table 18. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Producers in 2025
Table 20. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Company Evaluation Quadrant
Table 22. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Site of Key Manufacturer
Table 24. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market: Company Product Type Footprint
Table 25. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market: Company Product Application Footprint
Table 26. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Competitive Factors
Table 27. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters New Entrant and Capacity Expansion Plans
Table 28. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Mergers & Acquisitions Activity
Table 29. United States VS China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share (2021-2026)
Table 37. China Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share (2021-2026)
Table 42. Rest of World Based Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share (2021-2026)
Table 47. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Type (2021-2026) & (K Units)
Table 49. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Type (2027-2032) & (K Units)
Table 50. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Type (2021-2026) & (USD Million)
Table 51. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Type (2027-2032) & (USD Million)
Table 52. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Table 55. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Use Scenario (2021-2026) & (K Units)
Table 56. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Use Scenario (2027-2032) & (K Units)
Table 57. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Use Scenario (2021-2026) & (USD Million)
Table 58. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Use Scenario (2027-2032) & (USD Million)
Table 59. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Use Scenario (2021-2026) & (US$/Unit)
Table 60. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Use Scenario (2027-2032) & (US$/Unit)
Table 61. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Table 62. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 63. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Balloon Platform Mechanics (2027-2032) & (K Units)
Table 64. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Balloon Platform Mechanics (2021-2026) & (USD Million)
Table 65. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Balloon Platform Mechanics (2027-2032) & (USD Million)
Table 66. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 67. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Balloon Platform Mechanics (2027-2032) & (US$/Unit)
Table 68. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Application (2021-2026) & (K Units)
Table 70. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production by Application (2027-2032) & (K Units)
Table 71. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Application (2021-2026) & (USD Million)
Table 72. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Application (2027-2032) & (USD Million)
Table 73. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Application (2027-2032) & (US$/Unit)
Table 75. B. Braun Basic Information, Manufacturing Base and Competitors
Table 76. B. Braun Major Business
Table 77. B. Braun Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
Table 78. B. Braun Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. B. Braun Recent Developments/Updates
Table 80. B. Braun Competitive Strengths & Weaknesses
Table 81. Eurocor Basic Information, Manufacturing Base and Competitors
Table 82. Eurocor Major Business
Table 83. Eurocor Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
Table 84. Eurocor Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Eurocor Recent Developments/Updates
Table 86. Eurocor Competitive Strengths & Weaknesses
Table 87. Teleflex Basic Information, Manufacturing Base and Competitors
Table 88. Teleflex Major Business
Table 89. Teleflex Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
Table 90. Teleflex Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Teleflex Recent Developments/Updates
Table 92. Teleflex Competitive Strengths & Weaknesses
Table 93. Yinyi Basic Information, Manufacturing Base and Competitors
Table 94. Yinyi Major Business
Table 95. Yinyi Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product and Services
Table 96. Yinyi Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Yinyi Recent Developments/Updates
Table 98. Yinyi Competitive Strengths & Weaknesses
Table 99. Global Key Players of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Upstream (Raw Materials)
Table 100. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Typical Customers
Table 101. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Typical Distributors
LIST OF FIGURES
Figure 1. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Picture
Figure 2. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032) & (K Units)
Figure 5. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price (2021-2032) & (US$/Unit)
Figure 6. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Region (2021-2032)
Figure 7. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Region (2021-2032)
Figure 8. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032) & (K Units)
Figure 9. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032) & (K Units)
Figure 10. China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032) & (K Units)
Figure 11. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 14. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Market Share by Region (2021-2032)
Figure 15. United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 16. China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 17. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 18. Japan Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 19. South Korea Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 20. ASEAN Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 21. India Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 22. Producer Shipments of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Markets in 2025
Figure 25. United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share 2025
Figure 29. China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share 2025
Figure 31. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Type in 2025
Figure 33. Paclitaxel-based
Figure 34. limus
Figure 35. Other
Figure 36. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Type (2021-2032)
Figure 37. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Type (2021-2032)
Figure 38. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Figure 40. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Use Scenario in 2025
Figure 41. In-Stent Restenosi
Figure 42. De Novo
Figure 43. Small Vessel
Figure 44. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Use Scenario (2021-2032)
Figure 45. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Use Scenario (2021-2032)
Figure 46. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Use Scenario (2021-2032) & (US$/Unit)
Figure 47. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Figure 48. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Balloon Platform Mechanics in 2025
Figure 49. Semi-/Compliant
Figure 50. Non-compliant
Figure 51. Other
Figure 52. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Balloon Platform Mechanics (2021-2032)
Figure 53. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Balloon Platform Mechanics (2021-2032)
Figure 54. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Balloon Platform Mechanics (2021-2032) & (US$/Unit)
Figure 55. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Application in 2025
Figure 57. Hospitals
Figure 58. Clinics
Figure 59. Others
Figure 60. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Application (2021-2032)
Figure 61. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Application (2021-2032)
Figure 62. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Chain
Figure 64. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Procurement Model
Figure 65. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Model
Figure 66. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Picture
Figure 2. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032) & (K Units)
Figure 5. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price (2021-2032) & (US$/Unit)
Figure 6. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Region (2021-2032)
Figure 7. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Region (2021-2032)
Figure 8. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032) & (K Units)
Figure 9. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032) & (K Units)
Figure 10. China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production (2021-2032) & (K Units)
Figure 11. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 14. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Market Share by Region (2021-2032)
Figure 15. United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 16. China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 17. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 18. Japan Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 19. South Korea Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 20. ASEAN Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 21. India Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption (2021-2032) & (K Units)
Figure 22. Producer Shipments of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Markets in 2025
Figure 25. United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share 2025
Figure 29. China Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share 2025
Figure 31. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Type in 2025
Figure 33. Paclitaxel-based
Figure 34. limus
Figure 35. Other
Figure 36. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Type (2021-2032)
Figure 37. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Type (2021-2032)
Figure 38. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Figure 40. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Use Scenario in 2025
Figure 41. In-Stent Restenosi
Figure 42. De Novo
Figure 43. Small Vessel
Figure 44. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Use Scenario (2021-2032)
Figure 45. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Use Scenario (2021-2032)
Figure 46. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Use Scenario (2021-2032) & (US$/Unit)
Figure 47. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Figure 48. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Balloon Platform Mechanics in 2025
Figure 49. Semi-/Compliant
Figure 50. Non-compliant
Figure 51. Other
Figure 52. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Balloon Platform Mechanics (2021-2032)
Figure 53. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Balloon Platform Mechanics (2021-2032)
Figure 54. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Balloon Platform Mechanics (2021-2032) & (US$/Unit)
Figure 55. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Application in 2025
Figure 57. Hospitals
Figure 58. Clinics
Figure 59. Others
Figure 60. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Market Share by Application (2021-2032)
Figure 61. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Value Market Share by Application (2021-2032)
Figure 62. World Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Chain
Figure 64. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Procurement Model
Figure 65. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Model
Figure 66. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
